Literature DB >> 12010245

Influence of nitric oxide signalling pathways on pre-contracted human detrusor smooth muscle in vitro.

Annick Moon1.   

Abstract

OBJECTIVES: To assess the effects of nitric oxide (NO) donors on human detrusor strips in vitro under conditions which attempt to mimic those occurring in vivo during the tonic phase of bladder contraction, as NO may promote relaxation by modulating parasympathetic excitation contraction coupling.
MATERIALS AND METHODS: With ethical approval from the local ethics committee, human detrusor tissue was obtained from a heterogeneous clinical group after obtaining informed consent. Detrusor strips were dissected and mounted in a 1-mL, superfused organ bath. After pre-contraction with carbachol, the effect of NO donors, sodium nitroprusside (SNP) and S-nitro-N-acetylpenicillamine, a cell-permeable cyclic nucleotide analogue (dibutyl-cGMP), and inhibitors (methylene blue and ibuprofen) on isometric tension were assessed. All drugs were dissolved in Tyrode solution (pH 7.4), passed through a thermostatically controlled (36 degrees C) warming jacket and bubbled with 95% O2/5% CO2.
RESULTS: Both NO donors and db-cGMP evoked a complex response in pre-contracted tissue, i.e. relaxation, contraction or a transient relaxation followed by contraction. Inhibition of soluble guanylyl cyclase significantly attenuated NO-mediated contraction, indicating the involvement of cGMP, but this inhibition did not significantly affect the relaxant response. The relaxant response was also potentiated by ibuprofen. SNP and db-cGMP evoked similar responses, although the occurrence of the responses (relaxation, contraction or biphasic) was significantly different in normal and pathological human detrusor.
CONCLUSIONS: NO donors and db-cGMP modulate carbachol-evoked contraction of human detrusor smooth muscle in vitro. There is probably a NO/cGMP signalling pathway, with inhibition of endogenous cGMP by methylene blue, suggesting that SNP evokes contraction via cGMP. However, NO donors and db-cGMP evoked a complex response (relaxant, contractile or biphasic), suggesting that NO and cGMP may also act independently and/or via several pathways.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12010245     DOI: 10.1046/j.1464-410x.2002.02795.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  12 in total

1.  Recovery of urothelial mediator release but prolonged elevations in interleukin-8 and nitric oxide secretion following mitomycin C treatment.

Authors:  Sung Hyun Kang; Russ Chess-Williams; Shailendra Anoopkumar-Dukie; Catherine McDermott
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-02-03       Impact factor: 3.000

Review 2.  Modulation of lower urinary tract smooth muscle contraction and relaxation by the urothelium.

Authors:  Donna Sellers; Russ Chess-Williams; Martin C Michel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-05-28       Impact factor: 3.000

3.  Signalling pathways involved in sildenafil-induced relaxation of human bladder dome smooth muscle.

Authors:  S Oger; D Behr-Roussel; D Gorny; T Lebret; P Validire; X Cathelineau; L Alexandre; F Giuliano
Journal:  Br J Pharmacol       Date:  2010-07       Impact factor: 8.739

4.  Urinary dysfunction in transgenic sickle cell mice: model of idiopathic overactive bladder syndrome.

Authors:  Serkan Karakus; Uzoma A Anele; Fábio H Silva; Biljana Musicki; Arthur L Burnett
Journal:  Am J Physiol Renal Physiol       Date:  2019-06-19

5.  cAMP-dependent regulation of RhoA/Rho-kinase attenuates detrusor overactivity in a novel mouse experimental model.

Authors:  William Akakpo; Biljana Musicki; Arthur L Burnett
Journal:  BJU Int       Date:  2017-04-11       Impact factor: 5.588

6.  Benign prostatic hyperplasia/obstruction ameliorated using a soluble guanylate cyclase activator.

Authors:  Irina V Zabbarova; Youko Ikeda; Mark G Kozlowski; Pradeep Tyagi; Lori A Birder; Basu Chakrabarty; Subashan Kpg Perera; Rajiv Dhir; Adam C Straub; Peter Sandner; Karl-Erik Andersson; Marcus J Drake; Christopher H Fry; Anthony J Kanai
Journal:  J Pathol       Date:  2022-02-15       Impact factor: 9.883

7.  The effect of intravesical sodium nitroprusside on idiopathic detrusor overactivity.

Authors:  Fatih Tarhan; Erkan Erbay; Bilal Eryildirim; Gökhan Faydaci; Uethur Kuyumcuoğlu
Journal:  Urol Res       Date:  2004-02-07

8.  NO-Releasing Nanoparticles Ameliorate Detrusor Overactivity in Transgenic Sickle Cell Mice via Restored NO/ROCK Signaling.

Authors:  Serkan Karakus; Biljana Musicki; Mahantesh S Navati; Joel M Friedman; Kelvin P Davies; Arthur L Burnett
Journal:  J Pharmacol Exp Ther       Date:  2020-03-06       Impact factor: 4.030

Review 9.  The use of botulinum neurotoxin type A (BoNTA) in urology.

Authors:  A Apostolidis; C J Fowler
Journal:  J Neural Transm (Vienna)       Date:  2008-03-06       Impact factor: 3.575

Review 10.  Drugs Currently Undergoing Preclinical or Clinical Trials for the Treatment of Overactive Bladder: A Review.

Authors:  Silvia Joseph; Steffi A Maria; Jacob Peedicayil
Journal:  Curr Ther Res Clin Exp       Date:  2022-04-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.